Synergistic Heterojunction/Cu─N Coordination Engineering Drives Cuproptosis and PANoptosis for Sonodynamic Glioblastoma Therapy
Advanced Healthcare Materials · 2026-08 · 15 (31)
DOI: 10.1002/adhm.71451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.07.2026. Verfasst von Ming Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China. Hauptthemen laut MEDLINE: Cuproptosis, Copper, Glioblastoma, Ultrasonic Therapy. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, Youth Innovation Promotion Association of CAS, Suzhou Traditional Chinese Medicine Hospital Qingmiao Program.
Abstract (Originalsprache)
Glioblastoma (GBM) remains one of the most lethal intracranial malignancies due to its diffuse invasiveness and inevitable recurrence. Sonodynamic therapy (SDT) offers a noninvasive strategy for deep‐tissue tumor ablation; however, its efficacy is often limited by rapid electron–hole recombination in conventional sonosensitizers, resulting in insufficient reactive oxygen species (ROS). In this study, a biomimetic nanosonosensitizer is rationally engineered via synergistic type II heterojunction interface construction and Cu─N coordination electronic activation. By anchoring Cu─N coordinated carbon dots (Cu‐CDs) onto two‐dimensional (2D) nanosheets, the compact heterojunction enables spatial charge separation, while Cu─N motifs act as kinetic promoters to accelerate interfacial electron transfer. This co‐engineering strategy markedly enhances ultrasound (US) ‐triggered multi‐ROS generation, leading to amplified oxidative stress. Biologically, intracellular copper overload triggers cuproptosis via lipoylated protein aggregation, whereas ROS burst induces PANoptosis‐like cell death. Importantly, the synergistic death programs promote robust immunogenic cell death (ICD) with elevated Damage‐associated molecular patterns (DAMPs) release/exposur, thereby activating antitumor immunity and contributing to enhanced therapeutic efficacy against GBM. This work provides new insights into the rational design of highly efficient sonosensitizers and offers new dimensions for precision SDT‐based glioma sono‐immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Suzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
- Department of Biomaterials and Stem Cells, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science (CAS), Suzhou, China.
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu, China.
ORCID-Profile: Li Li
Förderung
- National Key R&D Program of China
- Youth Innovation Promotion Association of CAS
- Suzhou Traditional Chinese Medicine Hospital Qingmiao Program
- Suzhou Traditional Chinese Medicine Technology Development Plan
- Suzhou Science and Technology Development Plan Project
Zitieren
APA
Cheng, M., Wu, J., Heng, L., Liu, Y., Yao, J., Zhu, T., Zhu, Y., You, Q., Lei, Z., Wu, T., Dong, W., Yue, J., Qin, Y., & Li, L. (2026). Synergistic Heterojunction/Cu─N Coordination Engineering Drives Cuproptosis and PANoptosis for Sonodynamic Glioblastoma Therapy. Advanced Healthcare Materials, 15(31). https://doi.org/10.1002/adhm.71451
Vancouver
Cheng M, Wu J, Heng L, Liu Y, Yao J, Zhu T, et al. Synergistic Heterojunction/Cu─N Coordination Engineering Drives Cuproptosis and PANoptosis for Sonodynamic Glioblastoma Therapy. Advanced Healthcare Materials. 2026;15(31). doi:10.1002/adhm.71451
BibTeX
@article{Cheng2026,
author = {Cheng, Ming and Wu, Jie and Heng, Liru and Liu, Yan and Yao, Jinyu and Zhu, Tongtong and Zhu, Yongming and You, Qiannan and Lei, Zhubing and Wu, Tong and Dong, Wenfei and Yue, Juan and Qin, Yuanyuan and Li, Li},
title = {Synergistic Heterojunction/Cu─N Coordination Engineering Drives Cuproptosis and PANoptosis for Sonodynamic Glioblastoma Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {31},
doi = {10.1002/adhm.71451}
}
EUVIMED